Evidence map›Paper›PMID 28104741›Full record

ArticleJournal of nuclear medicine : official publication, Society of Nuclear Medicine2017

Recombinant Human Thyroid-Stimulating Hormone Versus Thyroid Hormone Withdrawal in

Donika Plyku, Robert F Hobbs, Kevin Huang, Frank Atkins, Carlos Garcia, George Sgouros, Douglas Van Nostrand

Open access · bronzeAbstract readCase ReportsComparative Study
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 1 pooled it
4.1field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 1 synthesis or guideline pooled it, 53 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Diagnostic Performance ofJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2022
    Article
  9. Article
  10. [European journal of nuclear medicine and molecular imaging · 2022
    Article
  11. Article
  12. Article
  13. Dosimetry in Clinical Radiopharmaceutical Therapy of Cancer: Practicality Versus Perfection in Current Practice.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Review
  14. Review
  15. Review
  16. Article
  17. BIGDOSE: software for 3D personalized targeted radionuclide therapy dosimetry.Quantitative imaging in medicine and surgery · 2020
    Article
  18. Article
  19. Comparative Dosimetry forJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2018
    Article
  20. Combined model-based and patient-specific dosimetry forEuropean journal of nuclear medicine and molecular imaging · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Donika PlykuDepartment of Radiology, Johns Hopkins University, School of Medicine, Baltimore, Maryland.
Robert F HobbsDepartment of Radiology, Johns Hopkins University, School of Medicine, Baltimore, Maryland.
Kevin HuangDepartment of Radiology, Johns Hopkins University, School of Medicine, Baltimore, Maryland.
Frank AtkinsMedstar Health Research Institute and Division of Nuclear Medicine, MedStar Washington Hospital Center, Washington, District of Columbia.
Carlos GarciaMedstar Health Research Institute and Division of Nuclear Medicine, MedStar Washington Hospital Center, Washington, District of Columbia.
George SgourosDepartment of Radiology, Johns Hopkins University, School of Medicine, Baltimore, Maryland.
Douglas Van NostrandMedstar Health Research Institute and Division of Nuclear Medicine, MedStar Washington Hospital Center, Washington, District of Columbia douglas.van.nostrand@medstar.net.
MedStar Washington Hospital Center · USJohns Hopkins Medicine · USJohns Hopkins University · US

Funding

Dose-Response in Radionuclide TherapyR01CA116477 · NCI · JOHNS HOPKINS UNIVERSITY · PI HOBBS, ROBERT FRANCOIS, SGOUROS, GEORGE · 2006 to 2022
$7.1M
NCI NIH HHS R01 CA116477
6 · The paper itself

Abstract

Patients with metastatic differentiated thyroid cancer (DTC) may be prepared using either thyroid-stimulating hormone withdrawal (THW) or recombinant human thyroid-stimulating hormone (rhTSH) injections before

Indexed as

Absorption, RadiationAdultHumansIodine RadioisotopesMaleMiddle AgedPositron Emission Tomography Computed TomographyPremedicationRadiopharmaceuticalsRadiotherapy DosageRecombinant ProteinsThyroid NeoplasmsThyrotropinTreatment OutcomeWhole-Body CountingIodine RadioisotopesRadiopharmaceuticalsRecombinant ProteinsThyrotropindifferentiated thyroid cancerdosimetryimagingradionuclide therapyradiopharmaceuticals

Identifiers

PMID28104741
PMCPMC5493009
OpenAlexW2578933508

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.